EKSO:NASDAQ
Ekso Bionics Holdings Inc
US$11.79
arrow_downward
-1.83%(-0.22) 1 天
US$11.96
arrow_upward
+1.44% (+0.17)bedtime盘后交易
休市： 5月1日, GMT-4 16:00:01 · USD
search
所有股票代码
1 天
5 天
1 个月
6 个月
年初至今
1 年
5 年
最大
| 股票代码 | 价格 | 涨跌额 | 涨跌幅 |
|---|
insights_auto正在为 EKSO 生成关键数据洞见…
开盘价
US$12.26
最高价
US$12.31
最低价
US$10.98
市值
四二〇一.二三万
平均成交量
七.三一万
成交量
四.七六万
52 周最高价
US$13.50
52 周最低价
US$2.75
每股收益
-US$4.91
Beta 版
〇.七八
流通股数
三五六.三〇万
员工人数
五〇
新闻报道
来自全网
资料
Ekso Bionics Holdings Inc. is a company that develops and manufactures powered exoskeleton bionic devices that can be strapped on as wearable robots to enhance the strength, mobility, and endurance of industrial workers and people experiencing paralysis and mobility issues after a brain injury, stroke, multiple sclerosis or spinal cord injury. They enable individuals with any amount of lower extremity weakness, including those who are paralyzed, to stand up and walk.
Ekso Bionics currently focuses in the health and industrial sectors.
The company's first commercially available health product was called EksoGT. Ekso Bionics is the original developer of HULC, now under military development by Lockheed Martin, and the current developers of EksoNR, which allows patients who are relearning to walk the ability to stand and take steps. In December 2022, Ekso Bionics acquired the Human Motion & Control business unit from Parker Hannifin which includes the Indego product line. This acquisition allowed Ekso Bionics to begin selling exoskeletons to those who have an SCI and want a personal exoskeleton to walk at home and in their community. Wikipedia
Ekso Bionics Holdings Inc简介